MELISSA GRIFFIN: Open Payments
NPI 1669431888 · CONNERSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$806 in 46 payments from 11 companies in 2025. Trend: 2023 $981 · 2024 $894 · 2025 $806
Food & beverage: $806
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 16 | $220 |
| Amgen Inc. | 8 | $139 |
| AstraZeneca Pharmaceuticals LP | 5 | $115 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $76 |
| Merck Sharp & Dohme LLC | 3 | $62 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $52 |
| SCPHARMACEUTICALS INC. | 1 | $39 |
| ABIOMED | 1 | $33 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $22 |
Products named: ELIQUIS, REPATHA, FARXIGA, VYNDAQEL, Kerendia, VERQUVO, JARDIANCE, FUROSCIX.
Industry payments across IN — which companies pay providers there.
